Skip to main content

Migraine and cannabis in Oklahoma

The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

Listed qualifying condition
✓ Yes
LEGAL
3 oz on person; 8 oz at…
POSSESSION
$100/yr
STATE FEE
7–21 d
TIMELINE
Listed qualifying condition. The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

Oklahoma statute and program

The Oklahoma Medical Marijuana Program is the operating authority for Oklahoma patient certification. The authoritative legal text is: Title 63 OK Stat. §§ 420 et seq.: Oklahoma Medical Marijuana Authority Act.

What the evidence says about cannabis and Migraine

Migraine is a recurrent neurological condition characterized by moderate-to-severe headache often unilateral, pulsating, and accompanied by nausea, vomiting, or sensitivity to light, sound, or smell. Some patients experience an aura (sensory or visual disturbance) preceding the headache. Chronic migraine is defined as 15 or more headache days per month for at least three months, with at least eight days meeting migraine criteria.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Migraine page.

How to qualify in Oklahoma

The Oklahoma Medical Marijuana Program requires the following registration steps for a Migraine patient (or any qualifying diagnosis):

  1. Get a written recommendation from any Oklahoma-licensed physician. Under State Question 788 (codified at 63 O.S. §420 et seq.), any Oklahoma-licensed MD or DO may issue a written recommendation for medical cannabis. The Oklahoma program is the broadest practitioner-discretion model in the United States — there is no enumerated qualifying-condition list. The physician determines that medical cannabis is appropriate for the patient using "the same accepted standards a reasonable and prudent physician would follow."
  2. Apply through the OMMA online portal. The patient creates an account on the Oklahoma Medical Marijuana Authority (OMMA) online portal, uploads the physician recommendation, a current Oklahoma driver license or state ID, a passport-style photo, and proof of Oklahoma residency. Two-year licenses are now standard since 2023 OMMA rule revisions.
  3. Pay the $100 state fee (or $20 for SoonerCare/Medicaid). The two-year Oklahoma medical marijuana patient license fee is $100, reduced to $20 for patients enrolled in SoonerCare (Oklahoma Medicaid) or Medicare. Caregivers register separately and pass a state background check. Fees are paid online during the OMMA application submission.
  4. Receive the license and purchase from any OMMA-licensed dispensary. OMMA patient licenses are typically issued within 14 days of complete application; expedited processing is available. Oklahoma allows possession of 3 ounces on the person, 8 ounces at home, 1 ounce of concentrate, 72 ounces of edibles, and 6 mature plus 6 seedling plants. Oklahoma honors out-of-state medical cards under its 30-day temporary license program ($100 application fee) and has the highest per-capita patient enrollment of any US state.
State registration fee
$100
Physician visit (typical)
$50–$150
Certification to card
7–21 days
Out-of-state patients
Eligible
Minors
Eligible with caregiver

For full Oklahoma registration steps, fees, and reciprocity rules, see the Oklahoma cannabis-laws page.

ICD-10 code

A certifying physician documenting Migraine for the Oklahoma medical cannabis program will typically record ICD-10 G43.909 or SNOMED-CT 37796009 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Oklahoma list Migraine as a qualifying condition for medical cannabis?

Yes. Oklahoma explicitly lists Migraine as a qualifying condition under Oklahoma Medical Marijuana Program. A patient with a documented Migraine diagnosis can pursue state-program certification with a physician registered in the state. The qualifying-condition list is set by state statute or regulation and may change. Inclusion on the list does not guarantee certification — a physician still has to evaluate the patient and decide that medical cannabis is appropriate for that specific case under Oklahoma rules.

How do I get a Oklahoma medical marijuana card for Migraine?

Step one is finding a physician licensed in Oklahoma who is registered with Oklahoma Medical Marijuana Program and willing to evaluate Migraine cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Oklahoma honors out-of-state medical cards under its reciprocity rules — uncommon, and worth verifying before relying on it. Verify the patient minimum age with the state program before applying. Confirm the current process with the state regulator before applying, because the rules change.

What does the evidence say about cannabis for Migraine?

For Migraine, evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). The mmjnow condition page for Migraine lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Migraine should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Migraine and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Migraine; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. Title 63 OK Stat. §§ 420 et seq.: Oklahoma Medical Marijuana Authority Actaccessed May 16, 2026
  2. Oklahoma Medical Marijuana Authorityaccessed May 16, 2026
  3. Wikipedia: Cannabis in Oklahomaaccessed May 16, 2026
  4. OMMA: Patient Application Fees and Processaccessed May 18, 2026
  5. OMMA: Out-of-State (Temporary) Patient Licenseaccessed May 18, 2026
  6. Oklahoma Legislature bill trackeraccessed May 18, 2026
  7. NORML: Oklahoma Laws & Penaltiesaccessed May 18, 2026
  8. National Academies of Sciences, Engineering, and Medicine (2017): The Health Effects of Cannabis and Cannabinoidsaccessed May 18, 2026
  9. NIH NINDS: Migraineaccessed May 16, 2026